M A N U S C R I P T
A C C E P T E D Introduction 2 Zika (ZIKV) is an emerging flavivirus belonging to the family Flaviviridae, which is 3 currently responsible for a major outbreak in the Americas (1). As of 7 th December 4 2016, a total of 69 countries and territories have reported evidence of vector-5 borne ZIKV transmission since the start of the outbreak in 2015 (2). 6 The disease usually presents as a self-limited febrile illness, but mounting data 7 have established an association between ZIKV infection and adverse pregnancy 8 and fetal outcomes, with microcephaly being the most prominent, as well as 9 other neurologic syndromes, especially Guillain-Barre Syndrome (3, 4) . By these 10 close associations, in February 2016 the World Health Organization (WHO) 11 declared that the situation represented a Public Health Emergency of 12 International Concern (PHEIC) (5) . Recently, during the fifth meeting of the 13 Emergency Committee on ZIKV convened by WHO, the team felt that ZIKV no 14 longer represented a PHEIC, but emphasis was made that it remains a significant 15 enduring public health challenge that requires a long-term response 16 mechanism(6). 17 The main mode of transmission of Zika virus disease (ZVD) in urban and suburban 18 environments is by mosquito bite -Aedes aegypti and, to a lesser extent, A. 19 
A C C E P T E D ACCEPTED MANUSCRIPT 4 albopictus (1). However, non-mosquito transmission does occur but the 1 magnitude of the contribution of different ZIKV transmission routes to initiate or 2 maintain the epidemics in different regions remains unclear (7) . Here we 3 summarize the current evidence about sexually acquired ZIKV infection. 4 Secondarily, we assess the shedding of ZIKV in genital fluids. We hope that by 5 assembling the available data we will be able to contribute to the much-needed 6 evidence to support the WHO's interim guidance regarding the prevention of the 7 sexual transmission of ZIKV. Furthermore, we highlight the gaps in the current 8 knowledge that should be addressed to improve our understanding of the 9 transmission of ZIKV through sex. 10 
Methods

11
Search strategy 12 This study is a systematic review, and the PRISMA guidelines were followed(8). 13 The PubMed and Scopus databases from inception to December 8, 2016, were 14 searched to identify published clinical reports describing ZIKV infection acquired 15 through sex, and studies reporting the presence of ZIKV in genital fluids. The 16 following keywords were used in search engines: "Zika", "Zika infection", "Zika 17 fever", "Zika virus disease", "Sex", and "Semen". Additionally, we searched for 18 unpublished sexually-acquired ZIKV cases which were notified to the WHO by 19 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 National International Health Regulations Focal Points (NFP) and the PROMED-1 mail database. Neither time nor language restrictions were imposed. Manual 2 searches were also performed from the reference lists of the included articles. 3 The study is registered at PROSPERO (CRD42016041475). 4 Study criteria 5 Published observational studies (i.e., case series, and case reports) were 6 considered for inclusion. Studies lacking primary data were excluded. Sexually 7 acquired infections were considered for individuals without a history of residing 8 or traveling to areas of active ZIKV transmission who acquired ZIKV infection from 9 a sex partner with ZIKV infection, as defined by WHO ZIKV disease interim case 10 definitions(9). For the sake of clarity, index subjects were those who were the 11 likely source of infection with suspected, probable, or confirmed ZIKV infection 12 residing in or with a history of travel to areas of active ZIKV transmission or a 13 recent ZIKV outbreak. Non-human cases were excluded. Moreover, eligible 14 studies could include individuals in whom the presence or persistence of ZIKV was 15 evaluated in the genital fluids throughout the disease process. Two review 16 authors (JM, TP) independently screened the titles and abstracts of studies based 17 on the inclusion criteria. If there was a disagreement, a consensus was arrived at 18 through discussion with a third reviewer.
Data extraction 1 We extracted the following key information from the included studies: study 2 design, country and date of publication, modes of sexual transmission, age and 3 clinical manifestations relative to the index patients, diagnostic workout of ZVD, 4 secondary incubation period relative to the other sex partner, presence of other 5 sexually transmitted infections (STI), country of ZIKV acquisition, timing of sexual 6 intercourse in relation to disease onset in the index case (i.e., before, during, or 7 after the symptom onset), and the investigations used to exclude other non-8 sexual transmission routes. 9 For the studies that evaluated the ZIKV shedding in genital fluids, we extracted 10 the timing and the viral load of ZIKV in genital fluids in relation to other specimens 11 tested (i.e., serum, saliva, urine, cerebrospinal fluid).
12
Aims
13
The primary aim was to assess the number of suspected, probable or confirmed 14 sexually-acquired ZIKV cases. The secondary aim was to describe the number of 15 ZIKV-infected cases in which ZIKV shedding in genital fluids was documented. 
Results
4
Our initial search result yielded 88 records, but only 33 articles were considered 5 for the qualitative analysis ( Figure 1) . A total of 18 reports described sexually-6 acquired ZIKV cases, whereas 21 described the kinetics of ZIKV in genital fluids. Six 7 articles described both outcomes. 8
Risk of bias assessment 9
Four studies were of low quality, 27 of medium quality and 2 of high quality, 10 indicating a moderate risk of bias for the total analysis ( Supplementary Tables 1 &   11 2).
12
Transmission of ZIKV through sexual intercourse 13 We found 18 studies reporting person-to-person transmission of ZIKV through 14 sexual intercourse, corresponding to 27 episodes of probable or confirmed sexual 15 transmission of ZIKV(11-28). Table 1 describes further confirmed by phylogenetic analysis in two cases (22, 27) . Investigations for 10 other sexually transmitted infections (STI) were conducted in two cases, and were 11 negative in both (17, 22) . The median time between onset of symptoms in the 12 index partner and presumed sexual transmission was 13 (range: 4-44) days.
13
Shedding of ZIKV in genital fluids 14 The description of the 21 studies that reported shedding of ZIKV in genital fluids 15 (15, 22, 23, 25, (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) is shown in Table Vero cells were also obtained (15, 35, 36, 44, 45) . 8 ZIKV shedding in female genital tract 9 No study reported long-term viral persistence in female genital secretions, but 10 shedding occurred up to 13 days after onset of symptoms, and an attempt to 11 culture ZIKV at the same time failed(31). for ZIKV in urine (2 days before to 91 days after symptom onset), serum (2 days 16 before to 34 days after symptom onset), cerebrospinal fluids (7 days after 17 symptom onset), and saliva (2 days before to 91 days after symptom onset) were 18 much shorter than genital secretion samples (3-188 days after symptom onset).
Hematospermia as a surrogate clinical marker of positive ZIKV-RNA in men 1 Hematospermia was reported in three studies, corresponding to four patients (16, 2 33, 41). It was the clinical sign that prompted seeking medical treatment in three 3 patients. One of them also reported symptoms of prostatitis(16). Hematospermia 4 was macroscopic in three, and microscopic in one. All of them had ZIKV-RNA 5 detected in the semen, and viable ZIKV particles were cultured in one case(41). 6 Other features concerning semen characteristics (i.e. sperm count, the presence 7 of leukocytes) were altered in two patients but reverted to normal after viral 8 clearance. 9
Discussion
10
The results of this review confirm (i) that ZIKV is potentially sexually transmitted 11 and (ii) that ZIKV may persist for a longer period after symptom onset in male 12 genital secretions. The confirmation that ZIKV may be a sexually transmitted 13 pathogen has wide implications for clinical care and public health policy(46). 2 Furthermore, we found that ZIKV could be sexually transmitted very late after 3 symptom onset (i.e., 44 days after symptom onset) due to its persistence in 4 semen. To date, the longest that ZIKV RNA was detected in semen was 188 days 5 after the onset of illness(43), with viable ZIKV RNA isolation in cell cultures 6 achieved as late as 69 days after symptom onset. Here we recognize the fact that 7 long-term persistence of ZIKV in male genital tract does not necessarily reflect 8 infectivity, and more research should be done to confirm ZIKV isolation and the 9 mechanisms of ZIKV adaptation and persistence in the genital tract. The patient in 10 whom ZIKV was detected in semen up to 188 days after symptom onset did not 11 infect his regular female partner, and that he had used condoms following 12 diagnosis(43); for the other patient, with 181 days detection in semen, no onward 13 transmission through sex was described (42). Therefore, despite the detection of 14 ZIKV in urine and saliva, condom use seemed effective in preventing ZIKV 15 transmission. 16 The current guidance about the prevention of sexual acquisition of ZIKV in regions 17 with no active ZIKV circulation states that both men and women returning from (48). 2 We acknowledge that the magnitude of person-to-person ZIKV transmission is 3 substantially underestimated, and the role of sexual-borne transmission is 4 potentially much larger than previously appreciated. A major limitation for better 5 estimation of the magnitude of sexual transmission of ZIKV is the lack of methods 6 that could ascertain this route in areas of active mosquito transmission. In an 7 elegant approach, Coelho et al., could partially overcome this limitation using 8 data on the incidence of ZIKV in 2015 to 2016, and dengue in 2015 to 2016, and 9 2013 for the city of Rio de Janeiro, Brazil, and suggested that women of 10 reproductive age were 90% more likely to acquire ZIKV than their male 11 counterparts(49). This is an important epidemiological study conducted in an area 12 of active ZIKV transmission, which controlled for gender-related health seeking 13 behavior or the systematic testing of pregnant women was the cause of higher 14 reporting of ZVD in females. Its implications are that controlling the vector alone 15 may not be sufficient to control ZVD and that safe sex is highly advisable (as it is 16 widely known but not widely practiced). 17 Our study has limitations. Firstly, we did not include studies that were reported in 
